Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI With Secretin Enhancement to Increase Conspicuity of Pancreatic Cancer

NCT01094626 is registered in ClinicalTrials.gov with Elizabeth Hecht as lead sponsor.

NCT NCT01094626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI With Secretin Enhancement to Increase Conspicuity of Pancreatic Cancer
Lead sponsor
Elizabeth Hecht
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2010
Completion date
March 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intraductal papillary mucinous neoplasm, pancreatic cancer